What Lies Beneath: Chinese Pharma Tycoon Alleged Paying Millions In Stanford Admission Scandal

On a quiet May Day holiday in China, a U.S. admission scandal involving a local high-flying pharma executive hits home hard.

US dollar and Yuan China which its are 2 biggest countries for economic growth.Now America and China announce tariff tax policy to make conflict.
Buchang Pharma co-founder Tao Zhao allerged paying $6.5mn to get daughter into Stanford Univ.

More from Drug Safety

More from Pink Sheet